Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
STMC chart is saying 400%+
STMC- you can feel it
it's STMC day
HYBE- Golden cross and MACD break
HYBE- $30,000,000 of shareholder value in active reserves and an additional estimated $145,000,000 in yet untapped reserves of current properties.
HYBE is moving, get in at the bottom.
Up 45%
HYBE- moving, get in at the bottom
HYBE.. NEWS still not reflecting
Hybrid Energy Holdings Announces Significant Expansion of Current Acquisition Portfolio Adding $175,000,000 in Proven [KCWKGSG]
RENO, NV, Feb 03 (MARKET WIRE) --
Hybrid Energy Holdings, Inc. (PINKSHEETS: HYBE) announced today
significant additions to its current acquisition portfolio.
The operations under acquisition span 9 properties and consistently
deliver profitably with strong recurring current and historical
cash-flows. This important expansion of the company's portfolio results
in 35,000,000 BCF of known reserves and delivers an estimated $30,000,000
of shareholder value in active reserves and an additional estimated
$145,000,000 in yet untapped reserves of current properties.
The equity-based transaction calls for the issuance of preferred stock at
a strike value of approximately $6.9 million and delivers immediate
profitability with actively productive, reliable properties and an
estimated $175,000,000 in down-hole proven reserves value.
The parties agreed to a new closing date for the expanded acquisitions to
be the 15th of February 2010. Full financial disclosure will be timely
filed with the OTC Disclosure service immediately subsequent to Closing.
The company will not perform a reverse-split or change its capitalization
structure as part of this transaction.
About Hybrid Energy Holdings
Hybrid Energy Holdings (HEH) acquires and operates profitable energy
companies with strong historical cash-flow and sustainable profitability.
HEH may acquire promising nascent energy technology or technology rights
as portfolio enhancing assets. HEH's acquisitions are focused primarily on
traditional and proven fuel production and the latest in energy
conservation and power co-generation technologies. HEH's fuel production
acquisitions provide expertise in the recovery of oil and gas reserves in
both mature and marginal fields. The company's operational teams deliver
production improvements and developmental and low risk exploration as
part of its acquisition strategy for its fuel producing subsidiaries.
HEH's primary business strategy is the acquisition of diverse, profitable
energy related assets that provide synergistic profits and revenue
enhancements across all portfolio companies.
anyone know the BA
HYBE im in.. this could be 1000% today
NEWS.. for those who sold yesterday.
ChromoCure, Inc. Announces Major Therapeutics Research "Project Boveri: Find the Cure" [KCVDMMF]
RENO, NV, Feb 02 (MARKET WIRE) --
ChromoCure, Inc. (PINKSHEETS: KKUR) announced today the launch of a major
new research initiative targeting Cancer Therapy and Cure. The Company
has realigned its business strategy due to corroboration by recent
Medical Research publications that both validated ChromoCure's
chromosomal/aneuploidy theory of cancer and immediately established the
company's proprietary ChromoSomal Scanner technology in the forefront of
both cancer detection and research. The company will announce new
partnerships, products, licensing, and laboratory activities based on
this research-oriented alignment.
Research has conclusively, and irrefutably demonstrated aneuploidy as a
more accurate predictor of cancer than cytological/histological analysis
or genetic marker-based diagnostics that are the only other methods in
existence today. ChromoCure's proprietary technology and understanding of
cancer also suggest non-toxic and non-invasive approaches to cancer
therapy and cure research.
The company's technology and research combined with unique insights
provided by the chromosomal theory of cancer paves the way for
non-invasive and non-toxic solutions to cancer therapeutics and disease
eradication. ChromoCure's ChromoSomal Scanner Technologies, encompassing
proprietary designs, processes, and algorithms, provides significant
advantage in delivering important and significant results in both therapy
and cure.
Support by these recent third party medical findings, the Company is
calling for a stepped up collaborative approach through its "Project
Boveri: Find the Cure" initiative; and is inviting industry, institutions,
medical research centers and government to partner in this initiative. The
company has already established a special section of its web site
dedicated to this project and research outreach. The Company's recently
announced diagnostic partnership program with pathologists and diagnostic
labs will be incorporated into Project Boveri in order to broaden
awareness of the company's technology.
The company will provide cancer detection and progression measurement
services using its own equipment to research partners participating in the
Project Boveri initiative. "Project Boveri" is named after Theodor Boveri
who first described the chromosomal/aneuploidy theory of cancer diagnosis
nearly a century ago.
The company will soon announce the details on various collaborative
research centers participating in "Project Boveri: Find the Cure".
About ChromoCure
ChromoCure develops and provides proprietary cancer detection systems and
technologies. The Company's proprietary ChromoCure CS200 Chromosomal
Scanner system has been proven accurate and efficient in the measurement
of the unique genomic characteristic found in 100% of all cancers and
never found in normal cells. The Company's detection technology has been
proven to have an effective accuracy of 100% for all cancers at all
stages. The Company believes its technology will become the worldwide
gold standard for cancer detection, progression measurement, and research
for both therapy and cure.
Safe-Harbor Statement
This release contains statements or projections regarding future
performance that is forward-looking statements as defined in the Private
Securities Litigation Reform Act of 1995. Actual results may differ
materially from those projected as a result of certain risks and
uncertainties. The company's filings contain various RISK FACTORS (and are
incorporated herein by reference) and should be read before any investment
decision.
ChromoCure, Inc.
www.ChromoCure.com
info@chromocure.com
Tel 1.775.636.654
Copyright 2010, Market Wire, All rights reserved.
No Im in at .011 from the last run.
guess Im just a pesimistic
and that was that!
and that was that!
bouncing off 50 day
next resistance is .0023
STMC +51% 6k vol
is there NEWS.
I have anb alert for news but cant find it
ChromoCure to Secure Patents on Proprietary Chromosomal Cancer Detection Technology as Foundation in Preparation for [KCNLMGD]
RENO, NV, Jan 27 (MARKET WIRE) --
ChromoCure, Inc. (PINKSHEETS: KKUR) -- The Company announced today, based
on the recent validation of its cancer detection approach and efficacy of
its proprietary Chromosomal Scanning Technology, that it has retained
Patent & Intellectual Property Attorneys to assess its growing
Intellectual Property portfolio and secure necessary filings and Patent
protections. A complex and innovative series of systems, processes, cell
preparation techniques and diagnostic algorithms are currently integrated
in ChromoCure's landmark Chromosomal Scanning Technology.
The Company recently announced it will accelerate the implementation of
its Cancer Therapy and Cure initiatives. The Intellectual Property audit
and subsequent Patent Applications and protections will provide the
required foundation for various research programs and collaborations.
ChromoCure's chromosomal approach to cancer detection, therapy and cure
has been validated by recent publications, including the Mayo Clinic
findings. Per the publication of the company's clinical collaboration and
testing, its proprietary Chromosomal Scanner technology was demonstrated
a reliable and effective automated technological system to detect
aneuploid cells in real-world specimens, that detection of aneuploid
cells is diagnostic of cervical lesions and that the Chromosomal Scanner
possesses superb performance at not only detecting cancer but achieving
the near theoretical maximum agreement with the collaborating clinic's
error containing data.
The Company's pioneering knowledge of cancer's chromosomal properties
invites very effective, non-toxic therapeutic strategies. ChromoCure's
understanding of cancer's chromosomal peculiarities provides the most
promising avenue for treatment and cure and reinforces its pioneering
status.
About ChromoCure
ChromoCure develops and provides proprietary cancer detection systems and
technologies. The Company's proprietary ChromoCure CS200 Chromosomal
Scanner system has been proven accurate and efficient in the measurement
of the unique genomic characteristic found in 100% of all cancers and
never found in normal cells. The Company's technology has been proven to
have an effective accuracy of 100% for all cancers at all stages and
believes its technology will become the worldwide gold standard for
cancer detection, progression measurement, and research for both therapy
and cure.
Safe-Harbor Statement
This release contains statements or projections regarding future
performance that is forward-looking statements as defined in the Private
Securities Litigation Reform Act of 1995. Actual results may differ
materially from those projected as a result of certain risks and
uncertainties. The company's filings contain various RISK FACTORS (and are
incorporated herein by reference) and should be read before any investment
decision.
Contact:
ChromoCure, Inc.
www.ChromoCure.com
info@chromocure.com
Tel 1.775.636.654
Copyright 2010, Market Wire, All rights reserved.
-0-
27Jan10 13:30 GMT
Symbols:
us;KKUR
Source MW MarketWire
Categories:
DRU HEA INW MNG NEWR MST/R MST/R/US MST/L/EN MST/R/US TGT/BGN
STMC and MXWF
MXWF-cross over happing- above 50day
yeah I fibbed
looks pretty thin..
we should all buy just $100-$200 wroth to try and get it some attention. might be able to move it a bit into next week.
Im gonna make a small buy after lunch maybe to get a few eyes.
MXWF- Chart Any Day now, Waiting for cross over and a bit of volume
http://stockcharts.com/h-sc/ui
If this can break the .012.... this will do the same as CSRH
anyone have Level2.. eom
VIPR Announces Notification Of The Arrival Of Equipment and Key Personnel To Its Misangachuki Singida-Londoni Gold
LAS VEGAS, NEVADA, Jan 05 (MARKET WIRE) --
VIPR Industries Inc. (PINK SHEETS: VIPR) ("VIPR") announces update to its
next phase of exploratory work which has commenced on its Misangachuki
Singida-Londoni gold prospect property, Tanzania.
VIPR and its management have been informed by JICL Consulting of the
arrival of key personnel and equipment to its Misangachuki
Singida-Londoni gold prospect property, which is on schedule and as
planned. As announced in its recent press release, VIPR Industries (the
"Company") has initiated an additional pitting and trenching exploration
program on its Misangachuki Singida-Londoni property, located in
Tanzania. Included will be a ground magnetic geophysics, sampling program
and geological mapping of the terrain. More detailed information on this
program can be viewed on its website and previous press release of
December 10, 2009. As previously indicated, depending on various factors
including weather, the program is anticipated to last anywhere between 60
to 120 days.
Target zones for the sampling were previously identified from data
received on past work performed. The additional results derived from this
program will be used to isolate a possible drilling program along with a
possible NI 43-101 report should the results prove positive to warrant
such programs.
The property is situated at the Misangachuki village in the Singida
region, north east of Singida town in Tanzania and referenced by 20
licenses. The property is situated within the Londoni greenstone belt, in
close proximity to Shanta's Singida project, drilling results have
intersected up to 2 meters @ 512 g/t and results indicate a significant
gold resource of over 543,000 oz which has since been upgraded to include
additional resources.
In addition, to this round of exploration the company is actively
searching and reviewing other potential acquisitions that may be in more
advanced stages and/or possess significant potential. Further updates to
be made available.
About VIPR Industries Inc.
VIPR Industries Inc. is a precious metals exploration and development
company focused on Gold, Uranium, Diamonds and other precious metal
resources and reserves through mergers, acquisitions and resource
development.
Safe Harbor
This news release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (The "Act"). In
particular, when used in the preceding discussion, the words "pleased,"
"plan," "confident that," "believe," "expect," or "intend to," and
similar conditional expressions are intended to identify forward looking
statements within the meaning of the Act and are subject to the safe
harbor created by the Act. Such statements are subject to certain risks
and uncertainties and actual results could differ materially from those
expressed in any of the forward-looking statements. Such risks and
uncertainties include, but are not limited to, general economic
conditions, inherent mining risks, market conditions, competitive
factors, the ability to successfully complete additional financings and
other risks described in the Company's filings and website, which all
investors are advised to view at
viprindustries.com/motion.asp?menuid=6266&lgid=1&siteid=100382.
For more information please visit www.viprindustries.com.
Contacts:
VIPR Industries Inc.
Investor Relations
(702) 940-0494
info@viprindustries.com
www.viprindustries.com
Copyright 2010, Market Wire, All rights reserved.
-0-
05Jan10 14:02 GMT
Symbols:
us;VIPR
Source MW MarketWire
Categories:
GDM INW MNG NEWR STL MST/I/ISS MST/L/EN MST/R/G7 MST/R/NME MST/R/US
TGT/BGN
I will be buying 10mil at open... but I think this news could go either way. there are some pos and some neg. we'll see
looks like the pattern of buys at open and sell after 10:00 has changed. this might be a good thing!
This stock, like many others... when they enter the downward spiral from a large run with no news, they will continue down until we receive news.
CLosing above 20 and 50 day MA,
Golden Cross is formed with one more day of .0004 or higher close.
May be good indicators
Dan, I dont think you realize how annoying you are!!
Please stop saying WEEEEE. I enjoy reading these posts until I reach yours.. Everytime I see your post I feel like punchig my screen!!!
level ii anyone>
IFSL reporting a profit in first 6 months
IFSL- a break of $.005 and this is gone
was that a fake drop... no takers
IFSL- share buy back to be announced at meeting tomorrow?
IFSL new HOD... missing the train
IFSL up 7 days in a row- Just broke res.